VivoSeq
Other

RCT

0

Pipeline Programs↗

5

Active Trials↗

2

Companies Involved↗

RCT is an early-stage landscape with 0 programs across 2 companies. The most active players are AstraZeneca, ReCode Therapeutics.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

58/100

Attrition Rate

26/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AstraZeneca logo

AstraZeneca

0 programs

PreclinicalR

ReCode Therapeutics

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

19

clinical trials

Completed7 · 37%
Recruiting4 · 21%
Withdrawn3 · 16%
Unknown status2 · 11%
Terminated2 · 11%
Active, not recruiting1 · 5%

Clinical Trials

Trial Activity

19 trials

Intravesical LGG VS Saline Bladder Wash RCT
Recruiting·MMedstar Health Research Institute·Phase 2·NCT05230511·120 enrolled
Clinical Study in Patients With DSRCT
Recruiting·IItalian Sarcoma Group·Phase 2·NCT07328425·20 enrolled
EA for BPS: an RCT and Study for Central Mechanism
Recruiting·TThe Third Affiliated hospital of Zhejiang Chinese Medical University·N/A·NCT05279963·84 enrolled
PRolaCT - Three Prolactinoma RCTs
Recruiting·LLeiden University Medical Center·Phase 4·NCT04107480·880 enrolled
D9319C00001- 1L OC Mono Global RCT
Active, not recruiting·AstraZeneca logoAstraZeneca·Phase 3·NCT04884360·366 enrolled
Effects of ACS in Twin With LPB: Study Protocol for a RCT
Completed·SSeoul National University Hospital·Phase 2/3·NCT03547791·848 enrolled
GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT
Completed·—·Phase 3·NCT03039049·328 enrolled
RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo
Completed·NNorwegian University of Science and Technology·Phase 4·NCT00184106·86 enrolled
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
Completed·AstraZeneca logoAstraZeneca·N/A·NCT06099067·239,990 enrolled
Pilot RCT Using Homeopathic Medicines in ASD
Completed·—·Phase 4·NCT07161804·54 enrolled
Multicenter Investigation of Limitation of Infarct Size (MILIS)
Completed·National Heart, Lung, and Blood Institute (NHLBI)·Phase 3·NCT00000493
Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects
Completed·RReCode Therapeutics·Phase 1·NCT05737485·9 enrolled
Knee Injection RCT
Terminated·UUConn Health·Phase 4·NCT03694821·18 enrolled
Pilot RCT Evaluating a One Stop Vein Clinic
Terminated·IImperial College London·N/A·NCT02557542·3 enrolled
MC RCT - BPO vs Adapalene
Withdrawn·UUniversity of Oklahoma·Phase 3·NCT05536882
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)